Treatment Registry
TR-0383 ActiveRecorded September 2026Last verified October 2026

Brand tirzepatide

Sold by Aquivia Health · every brand tirzepatide record

The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.

Price

TermPublished rateCharged today
Zepbound per four-week fill

Price conditions have not been established; the quoted figure is not a verified recurring rate.

“$1,399”

$1,399Per 4 weeksCharged today$1,399
Price sources
Visit Aquivia Health

We earn nothing from this link. It opens Aquivia Health's website without a paid referral.

History

Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.

  • September 2026 — Entry added to the register

Sourcing and terms

PharmacyPartner network: RedRock Pharmacy; Health Warehouse; Precision Compounding Pharmacy; Triad Rx (individual dispensing pharmacy not specified)
StatesNot disclosed
PrescriberNot disclosed
CancellationPublished deadlines differ: the terms say five days before renewal, while the cancellation policy says 72 hours. Confirm which applies before enrolling. The policy allows a refund within the first 72 hours if no service has been received, and refunds following medical disqualification. Monthly plans do not receive ordinary current- or prior-month refunds; prepaid plans of two or more months refund months for which no medication shipped.
MembershipNot disclosed
Consult feeNot disclosed

Recorded from aquiviahealth.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. October 2026 — The advertised brand-name price covers a four-week fill rather than a calendar month. Shipping, coaching and ongoing support are listed, but confirm any separate clinical charge, device and your pharmacy before paying. The pharmacy partner list does not identify who will dispense this prescription.

2 further notes concern other Aquivia Health programs and sit on the provider record.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0383
Medication category
brand tirzepatide
Readings
3

Related records

Cite this entry

Treatment Registry. (2026). Aquivia Health — brand tirzepatide (TR-0383). Last verified October 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0383

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.